FDA Inspection 1118442 — Odan Laboratories Ltd

Odan Laboratories Ltd — FEI 3002706162

The FDA completed an inspection of Odan Laboratories Ltd on February 20, 2020 in Pointe-Claire. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 20, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pointe-Claire (Canada)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
191221 CFR 211.166(a)Written program not followed
201121 CFR 211.188(a)Accurate reproduction